[Immunosuppressive treatment about the patient operated facial allotransplantation in perioperative period].
OBJECTIVE
To investigate the perioperation medication on the first patient who was operated facial allotransplantation, including immunosuppressive drug and adjunctive drug, so that to search a effective medication schedule to the patient operated facial allotransplantation.


METHODS
FK506, MMF, Prednisone and Zenapax was performed as immunosuppressive regiment in perioperative treatment; meanwhile, anti-infectives was administered to take precautions against all sorts of infections, such as bacterium, virus and fungus. Furthermore, all kinds of adjunctive drug, Losec, glucurolactone and so on, was administered to protect those function of stomach, liver, kidney and so on. Clinical observations were made on the signs and symptoms of graft survival or rejection, as well as immunological indexes were tested in laboratory. Biopsies of graft were also made at 30 d after operation. Side effect and complication of drug was monitored, in case the body suffered harm.


RESULTS
Facial allograft was survived, and the temperature and color of skin were normal. Swelling of tissue was gradually subsidise after 4 days, and recovered in a half month. The count and ratio between Th and Ts were normal, skin Biopsies of every time had no found of hyperacute or acute rejection, and side effect and complication of drug had no monitored.


CONCLUSIONS
The regiment of perioperation medication was successfully performed.
Zhang
Xu-Dong
XD
Institute of Plastic surgery, Xijing Hospital, the Forth Military Medical University, Xi'an 710032, China.
Guo
Shu-Zhong
SZ
Han
Yan
Y
Lu
Bing-Lun
BL
Wen
Ai-Dong
AD
Yang
Li
L
Zhang
Hui
H
Wang
Da-Tai
DT
Liu
Yun-Jing
YJ
Fan
Xing
X
D000328:Adult; D005145:Face / Q000601:surgery*; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D008297:Male; D016378:Tissue Transplantation / Q000379:methods*; D014184:Transplantation, Homologous
D007166:Immunosuppressive Agents